Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly
- PMID: 27122487
- PMCID: PMC6127866
- DOI: 10.1136/heartjnl-2015-308764
Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly
Abstract
The burgeoning evidence of patients diagnosed with sigmoidal hypertrophic cardiomyopathy (HCM) later in life has revived the quest for distinctive features that may help discriminate it from more benign forms of isolated septal hypertrophy often labelled ventricular septal bulge (VSB). HCM is diagnosed less frequently than VSB at older ages, with a reversed female predominance. Most patients diagnosed with HCM at older ages suffer from hypertension, similar to those with VSB. A positive family history of HCM and/or sudden cardiac death and the presence of exertional symptoms usually support HCM, though they are less likely in older patients with HCM, and poorly investigated in individuals with VSB. A more severe hypertrophy and the presence of left ventricular outflow obstruction are considered diagnostic of HCM, though stress echocardiography has not been consistently used in VSB. Mitral annulus calcification is very prevalent in both conditions, whereas a restrictive filling pattern is found in a minority of older patients with HCM. Genetic testing has low applicability in this differential diagnosis at the current time, given that a causative mutation is found in less than 10% of elderly patients with suspected HCM. Emerging imaging modalities that allow non-invasive detection of myocardial fibrosis and disarray may help, but have not been fully investigated. Nonetheless, there remains a considerable morphological overlap between the two conditions. Comprehensive studies, particularly imaging based, are warranted to offer a more evidence-based approach to elderly patients with focal septal thickening.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Figures
Comment in
-
T1 mapping with cardiovascular magnetic resonance: an emerging clinical biomarker.Heart. 2017 Feb 15;103(4):326. doi: 10.1136/heartjnl-2016-310678. Heart. 2017. PMID: 28130438 No abstract available.
-
T1 mapping with cardiovascular magnetic resonance: an emerging clinical biomarker.Heart. 2017 Feb 15;103(4):326. doi: 10.1136/heartjnl-2016-310680. Heart. 2017. PMID: 28130439 No abstract available.
References
-
- Krasnow N Subaortic septal bulge simulates hypertrophic cardiomyopathy by angulation of the septum with age, independent of focal hypertrophy. An echocardiographic study. J Am Soc Echocardiogr 1997;10:545–55. - PubMed
-
- Swinne CJ, Shapiro EP, Jamart J, et al. Age-associated changes in left ventricular outflow tract geometry in normal subjects. Am J Cardiol 1996;78:1070–3. - PubMed
-
- Belenkie I, MacDonald RP, Smith ER. Localized septal hypertrophy: part of the spectrum of hypertrophic cardiomyopathy or an incidental echocardiographic finding? Am Heart J 1988;115:385–90. - PubMed
-
- Shapiro LM, Howat AP, Crean PA, et al. An echocardiographic study of localized subaortic hypertrophy. Eur Heart J 1986;7:127–32. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources